4 min read
4 min read
Cannabis related businesses (CRBs) have relied heavily on private equity loans and credit lines over the past five years, with limited access, creating an uneven cost of capital and wide variability in the terms available. As the constraints on affordable capital continue to take a toll, institutional debt will assume a central role in how these companies fund growth and stabilize cash flow. The shift is gradual, but it is becoming increasingly relevant for financial institutions evaluating where the next opportunity lies within their cannabis banking programs.
Whitney Economics’ 2024 Cannabis Debt Report illustrated a clear pattern where CRBs are seeking institutional debt to replace expensive private loans they secured earlier in the cycle, and many are obtaining structured lending products more aligned with traditional commercial banking expectations. The industry’s debt needs have extended beyond construction financing or emergency working capital. CRBs with operational track records are looking for term loans and revolving credit facilities that support expansion and equipment upgrades. This resembles lending patterns seen in other sectors where credit availability becomes a lever for growth rather than a last resort during distress.
Even with this movement toward more conventional financing, the path for financial institutions is not straightforward. Cannabis remains federally illegal, creating added layers of compliance, due diligence, and ongoing monitoring. The absence of standardized risk assessment methodologies has also complicated lending decisions and increased underwriting costs. As noted in an American Banker article by our CEO, the lack of transparent, data-backed credit evaluation has contributed to uneven pricing and uncertainty for all parties involved.
This is where purpose-built cannabis lending programs become important. Banks and credit unions that have already developed cannabis banking capabilities are in a natural position to extend into lending and credit. They understand state regulatory structures, have visibility into cash flow patterns, and maintain ongoing compliance oversight. Expanding deposit-only programs into lending requires deeper credit analysis, but the underlying relationship infrastructure is already in place.
To build a smart lending strategy, financial institutions will look beyond financial information and ownership credit profiles and require data on the operational health and regulatory compliance of CRBs. Loan performance will depend on factors such as verified revenue, tax compliance, license status, operational efficiency, inventory management, and supply chain continuity. To properly understand the relationship between this data and how it impacts borrower creditworthiness, financial institutions will need to utilize industry-specific credit risk tools. As debt markets expand, financial institutions that can consistently evaluate those factors will be able to offer products that align rate with risk rather than rely on broad assumptions about the industry.
Key Insight
Cannabis debt markets are entering a phase where traditional credit expectations and industry-specific risk factors are intersecting. Financial institutions that develop cannabis lending programs grounded in objective, data-backed credit risk analysis will be best positioned to serve the growing demand for structured financing while managing regulatory and portfolio risk.
Industry trends also point toward a more competitive lending environment as federal reform progresses. Rescheduling, if finalized, will not eliminate regulatory complexity, but it may reduce uncertainty and expand the pool of institutions willing to consider the asset class. When viewed alongside the steady increase in debt demand, financial institutions have a narrow window to prepare. Those that establish lending frameworks today will be positioned to respond as creditworthy CRBs seek more reliable, long-term financing partners.
Cannabis lending is moving from a niche product to an essential component of how the industry funds itself. Banks and credit unions that recognize this shift can play a stabilizing role in a market that is ready for more structured and disciplined credit solutions.
In maturing markets, experienced operators with strong business fundamentals and cash-flow are seeking institutional capital that supports growth opportunities and working capital rather than expensive private debt. Many are replacing earlier, expensive financing with commercial loans that better match their operational stability and long-term plans.
Not only does cannabis remain federally illegal, which increases the compliance burden and requires more detailed, ongoing monitoring, but risk analysis and underwriting must incorporate cannabis-specific operational and regulatory factors that traditional credit risk assessments do not fully capture.
The report highlights a growing appetite for debt across the sector and reinforces that operators are moving toward financing structures that resemble conventional commercial lending. It confirms the shift from opportunistic equity capital to more disciplined and strategic debt financing.
Financial institutions should prioritize objective, data-driven risk assessment models that account for verified revenue, license integrity, tax compliance, and operational resilience. These factors support stronger underwriting and create a foundation for sustainable lending programs.
Ready to Get Expert Guidance?
Our team partners with banks, credit unions, and lenders to turn complex cannabis credit risk into lending opportunities.
Let’s find the right path forward together.
